Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy
作者
David A. Reardon,Annick Desjardins,Katherine B. Peters,Sridharan Gururangan,John H. Sampson,Jeremy N. Rich,Roger E. McLendon,James E. Herndon,Jennifer Marcello,Stevie Threatt,Allan H. Friedman,James J. Vredenburgh,Henry S. Friedman
出处
期刊:Journal of Neuro-oncology [Springer Science+Business Media] 日期:2010-09-18卷期号:103 (2): 371-379被引量:99